Cellectar Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Cellectar Biosciences's estimated annual revenue is currently $3.5M per year.
- Cellectar Biosciences's estimated revenue per employee is $129,630
- Cellectar Biosciences's total funding is $33.5M.
Employee Data
- Cellectar Biosciences has 27 Employees.
- Cellectar Biosciences grew their employee count by 35% last year.
Cellectar Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Executive Assistant to CEO | Reveal Email/Phone |
2 | VP, Business Strategy and Analytics | Reveal Email/Phone |
3 | VP, Marketing and Strategic Alliances | Reveal Email/Phone |
4 | VP & CFO | Reveal Email/Phone |
5 | VP, Head Medical Affairs Cellectar Biosciences | Reveal Email/Phone |
6 | SVP | Reveal Email/Phone |
7 | Director Manufacturing Operations | Reveal Email/Phone |
8 | Chief Commercial Officer | Reveal Email/Phone |
9 | President, CEO & Director | Reveal Email/Phone |
10 | Chief Operating Officer | Reveal Email/Phone |
Cellectar Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is Cellectar Biosciences?
Cellectar LLC is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar\'s novel product candidates combine lipid-like molecules, phospholipid ethers (PLEs), with radioisotopes that destroy malignant cells. Cellectar\'s products\' unique mechanism of action is based on their selective accumulation and retention in malignant tumors and not normal cells. The company\'s operations are based in Madison, WI. Cellectar haspreviously raised approximately $9.0 million from angel investors; including Continuum Investment Partners
keywords:Biotechnology
$33.5M
Total Funding
27
Number of Employees
$3.5M
Revenue (est)
35%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cellectar Biosciences News
Cellectar Biosciences (NASDAQ:CLRB) Earns Sell Rating from Analysts at StockNews.com. Posted by admin on Apr 19th, 2022.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Short Interest Update. Posted by admin on Apr 16th, 2022. Share on Twitter Share on Facebook Share on LinkedIn...
About Cellectar Biosciences, Inc. Cellectar Biosciences is focused on the discovery and development of drugs for the treatment of cancer. The...
Cellectar Biosciences, Inc. announced it has been awarded a peer-reviewed National Institutes of Health (NIH) Phase II Small Business Innovation Research (SBIR) grant of approximately $2 Million from the National Cancer Institute (NCI). The company is currently conducting a global pivotal study ...
Based on its previous fundraising, Cellectar appears to be among Wisconsin’s most promising health care start-ups. The company raised $13 million in early 2008 to fund operations, as well as its Phase 1 trial, Wisconsin Technology News reported. That round was led by Venture Investors LLC, whic ...
Other Companies in Florham Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.2M | 31 | 0% | N/A |
#2 | $6.2M | 31 | -3% | N/A |
#3 | $7.4M | 32 | 0% | N/A |
#4 | $5.6M | 32 | 3% | N/A |
#5 | $5.4M | 32 | -9% | N/A |